Erika L. Finanger
Neuromusculoskeletal Medicine
3181 SW Sam Jackson Park Rd
Portland, OR 97239
Portland, OR 97239
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
New hope for older SMA patients with next-generation self-complementary AAV gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 28, 2025
Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons.
Journal: Annals of clinical and translational neurology
Published: February 27, 2025
Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T.
Journal: Brain : a journal of neurology
Published: October 03, 2024
The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.
Journal: medRxiv : the preprint server for health sciences
Published: April 08, 2024
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy.
Journal: Annals of clinical and translational neurology
Published: April 17, 2023
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: December 21, 2022
Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance.
Journal: Journal of neuromuscular diseases
Published: April 25, 2022
Development of Contractures in DMD in Relation to MRI-Determined Muscle Quality and Ambulatory Function.
Journal: Journal of neuromuscular diseases
Published: February 06, 2022
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial.
Journal: Journal of neuromuscular diseases
Published: June 14, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial.
Journal: Neuromuscular disorders : NMD
Published: September 10, 2020
Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
Journal: Radiology
Published: April 15, 2020
Walking activity in a large cohort of boys with Duchenne muscular dystrophy.
Journal: Muscle & nerve
Published: September 03, 2019
Last Updated: 09/26/2026